DISCOVER: A single-site double-blind placebo-controlled randomized mechanistic crossover trial to assess the influence of boDy weIght on aSpirin-triggered speCialized prO-resolVing mEdiatoRs
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Inflammation
-
Age: Between 40 Year(s) - 70 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Age between 40 and 70 years without known atherosclerotic cardiovascular disease (ASCVD)
You may not be eligible for this study if the following are true:
-
- Atherosclerotic cardiovascular disease (ASCVD)
- Anti-platelet medication use in the past 7 days
- Aspirin intolerance or allergy
- Known bleeding or clotting disorder
- Chronic inflammatory or connective tissue disease
- Immunological deficiency
- Diabetes mellitus
- Prior gastric or bariatric surgery
- Active smoking
- Platelet count <100,000
- Use of omega-3 fatty acid supplementation
- Use of drugs or supplements known to inhibit COX-1/COX-2/lipoxygenases
- Corticosteroid use
- Recent initiation or change in dose of statin therapy
- Pregnancy
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.